CatSci Ltd, an award-winning innovation partner for medicines development, will be attending the Anglonordic Life Science Conference 2024, taking place in County Hall London on 18th April 2024.
Akil Jacobs Holden, our Business Development Executive, will be attending Anglonordic London. He is looking forward to networking with the industry and discussing how CatSci can address your CMC challenges with our in-depth drug development expertise. Our capabilities span from preclinical through all phases of development, commercialisation and post approval changes across process chemistry, GMP-analytical, HPAPIs, material sciences and preformulation, and oligonucleotides. From candidate selection through product launch and beyond, CatSci can de-risk your pharmaceutical pipeline and accelerate your path to clinic.
If you would like to book a meeting with Akil to discuss how we’ve helped companies with their route scouting, process design & optimisation and scale-up needs, get in touch here.